Statistics
Publications
18
Citations
1.7K
H-Index
17
Active since
2004
A. Kathleen McClendon is an author at Thomas Jefferson University specializing in molecular oncology, medicine, and molecular biology.
Publications per year
2004–2015
18
18
CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy
A. Kathleen McClendon, Jeffry L. Dean, Dayana B. Rivadeneira et al. · Cell Cycle · 2012 · 170 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 18